The Hungarian Society of Experimental and Clinical Pharmacology (HUPHAR) organized the HUPHAR2025 – International Pharmacology Conference: focus on drug discovery and innovation conference in Mátraháza, Hungary, between 4-6 June 2025. The conference paid special attention to young researchers: provided great opportunities to present and discuss their results.
On June 5th, Dr. András Dinnyés represented Biotalentum Ltd. in a dual role, serving as both a session chair of section ATMP Development Towards Clinical Application and as a speaker (Title: Challenges in Clinical Translation of Advanced Therapy Medicinal Products).
Laura Colar Zanjko presented on “Implementation of standardized in vitro toxicity assays for antisense oligonucleotide therapies for patients with ultra rare diseases”.
A Haplo-IPS COST action was presented by Dr. Begonia Aran’s talk: “Generation of human induced Pluripotent Stem Cells from Haplo-selected Cord Blood samples. HAPLO-iPS (CA21151)”
The NHPig project was introduced by Barbara Kessler presenting “Novel pig models for preclinical development of new drug modalities and xenoorgans”.
Recent Comments